tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SNDX Stock Latest News

Syndax price target raised to $35 from $22 at Barclays
The FlySyndax price target raised to $35 from $22 at Barclays
1d ago
SNDX
Syndax price target lowered to $33 from $40 at JPMorgan
PremiumThe Fly
Syndax price target lowered to $33 from $40 at JPMorgan
13d ago
SNDX
Syndax Pharmaceuticals: Q3 Earnings Call Highlights
PremiumCompany Announcements
Syndax Pharmaceuticals: Q3 Earnings Call Highlights
21d ago
SNDX
Syndax price target raised to $38 from $35 at UBS
PremiumThe Fly
Syndax price target raised to $38 from $35 at UBS
21d ago
SNDX
Strong Growth Potential and Market Expansion Justify Buy Rating for Syndax Pharmaceuticals
PremiumRatings
Strong Growth Potential and Market Expansion Justify Buy Rating for Syndax Pharmaceuticals
21d ago
SNDX
Syndax Pharmaceuticals: Strategic Advancements and Growth Potential Reinforce Buy Rating
PremiumRatingsSyndax Pharmaceuticals: Strategic Advancements and Growth Potential Reinforce Buy Rating
21d ago
SNDX
Syndax price target raised to $22 from $19 at Barclays
Premium
The Fly
Syndax price target raised to $22 from $19 at Barclays
22d ago
SNDX
Syndax Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Syndax Pharmaceuticals Reports Strong Q3 2025 Growth
22d ago
SNDX
Syndax reports Q3 EPS (70c), consensus (71c)
PremiumThe Fly
Syndax reports Q3 EPS (70c), consensus (71c)
22d ago
SNDX
Syndax sees operating expense base remaining stable over next few years
PremiumThe Fly
Syndax sees operating expense base remaining stable over next few years
22d ago
SNDX
Syndax options imply 10.9% move in share price post-earnings
PremiumThe Fly
Syndax options imply 10.9% move in share price post-earnings
22d ago
SNDX
Syndax announces Revuforj, Niktimvo data accepted for presentation at ASH 2025
PremiumThe Fly
Syndax announces Revuforj, Niktimvo data accepted for presentation at ASH 2025
22d ago
SNDX
SNDX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSNDX Upcoming Earnings Report: What to Expect?
25d ago
SNDX
Syndax Pharmaceuticals Launches Promising Phase 3 AML Study with Revumenib
Premium
Company Announcements
Syndax Pharmaceuticals Launches Promising Phase 3 AML Study with Revumenib
29d ago
SNDX
Syndax Pharmaceuticals’ Revumenib Study: A Potential Game-Changer in Leukemia Treatment
Premium
Company Announcements
Syndax Pharmaceuticals’ Revumenib Study: A Potential Game-Changer in Leukemia Treatment
29d ago
SNDX
Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment
PremiumCompany Announcements
Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment
29d ago
SNDX
Syndax Pharmaceuticals’ Promising AML Study Update: Key Insights for Investors
PremiumCompany Announcements
Syndax Pharmaceuticals’ Promising AML Study Update: Key Insights for Investors
29d ago
SNDX
Syndax price target raised to $27 from $26 at BofA
PremiumThe Fly
Syndax price target raised to $27 from $26 at BofA
29d ago
SNDX
Buy Rating Reaffirmed for Syndax Pharmaceuticals Despite Black Box Warning on Revuforj
PremiumRatings
Buy Rating Reaffirmed for Syndax Pharmaceuticals Despite Black Box Warning on Revuforj
30d ago
SNDX
Buy Rating for Syndax Pharmaceuticals Driven by FDA Approval of Revuforj and Market Expansion Potential
PremiumRatingsBuy Rating for Syndax Pharmaceuticals Driven by FDA Approval of Revuforj and Market Expansion Potential
30d ago
SNDX
Syndax Pharmaceuticals Gains FDA Approval for Revuforj
Premium
Company Announcements
Syndax Pharmaceuticals Gains FDA Approval for Revuforj
1M ago
8K
SNDX
Syndax trading resumes
Premium
The Fly
Syndax trading resumes
1M ago
SNDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >